CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES
MATTHEW R. WEIR, MD, Editor; RAJIV AGARWAL, MD, MS; PETER ROSSING, MD, DMSc; MUHAMMAD SHARIQ USMAN, MD; MUHAMMAD SHAHZEB KHAN, MD, MSc; JAVED BUTLER, MD, MPH, MBA; KEITH C. NORRIS, MD, PhD; SAM DAGOGO-JACK, MD, DSc; SANDRA C. NAAMAN, MD, PhD; GEORGE L. BAKRIS, MD, MA
Published: 5/25/2021
This publication has been supported by unrestricted educational grants to the American Diabetes Association from AstraZeneca and Bayer.
• Introduction
• Pathogenesis of Diabetic Nephropathy
• Risk Factors, Symptoms, Biomarkers, and Stages of Chronic Kidney Disease
• The Interplay Between Diabetes, Cardiovascular Disease, and Kidney Disease
• Socioeconomic and Racial Disparities Related to Chronic Kidney Disease and Type 2 Diabetes
• Screening, Monitoring, Prevention, and Treatment Strategies for Chronic Kidney Disease in Patients with Type 2 Diabetes
• Slowing Diabetic Kidney Disease Progression: Where Do We Stand Today?
• Conclusion
• References
Read the Monograph
PDF Version
THE ROLE OF BLOOD GLUCOSE MONITORING IN DIABETES MANAGEMENT
RUTH S. WEINSTOCK, MD, PHD, FACE, FACP; GRAZIA ALEPPO, MD, FACE, FACP; TIMOTHY S. BAILEY, MD, FACE, FACP, CPI; RICHARD M. BERGENSTAL, MD; WILLIAM A. FISHER, PHD; DEBORAH A. GREENWOOD, PHD, RN, BC-ADM, CDCES, FADCES; LAURA A. YOUNG, MD, PHD
Published: 10/19/2020
This publication has been supported by unrestricted educational grants to the American Diabetes Association from Ascensia and Lifescan.
• Abstract
• BGM Accuracy
• Recommendations for BGM use
• Using BGM Data to Achieve Treatment Goals
• Overcoming Barriers to BGM
• Use of BGM in CGM Users
• Innovations in BGM
• Conclusions
Read the Monograph
PDF Version
Person-Centered, Outcomes-Driven Treatment: A New Paradigm for Type 2 Diabetes in Primary Care
STEWART B. HARRIS, CM, MD, MPH, FCFP, FACPM; ALICE Y.Y. CHENG, MD, FRCPC; MELANIE J. DAVIES, CBE, MBChB, MD, FRCP, FRCGP, FMedSci; HERTZEL C. GERSTEIN, MD, MSc, FRCPC; JENNIFER B. GREEN, MD; NEIL SKOLNIK, MD
Published May 1, 2020
This publication has been supported by unrestricted educational grants to the American Diabetes Association from Eli Lilly and Company and Novo Nordisk.
• Abstract
• An Approach Made for Primary Care
• A New Approach for a New Era: The Case for Person-Centered Care
• Preventing Cardiovascular Events Across the Continuum of Risk
• Renal Protection Across the Continuum of Risk
• Keeping an Eye on Glycemic Control
• Conclusions
Read the Monograph
PDF Version
Diagnosis and Management of Diabetic Foot Infections
ANDREW J.M. BOULTON, MD, DSC (HON), FACP, FRC; DAVID G. ARMSTRONG, DPM, MD, PHD; MATTHEW J. HARDMAN, PHD; MATTHEW MALONE, PHD, FFPM RCPS (Glasg); JOHN M. EMBIL, MD, FACP, FRCPC; CHRISTOPHER E. ATTINGER, MD; BENJAMIN A. LIPSKY, MD, FACP, FIDSA, FRCP (London), FFPM RCPS (Glasg); JAVIER ARAGÓN-SÁNCHEZ, MD, PHD; HO KWONG LI, MBBS, MRCP (UK), DTM&H; GREGORY SCHULTZ, PHD; ROBERT S. KIRSNER, MD, PHD
Published January 7, 2020
This publication was supported by unrestricted educational grants to the American Diabetes Association from Healogics, Inc., and Organogenesis, Inc.
Read the Monograph
PDF Version
• Introduction
• How Infection Impairs Wound Healing
• Biofilms in the Context of Diabetic Foot Ulcers (DFUs)
• Evolving Microbiology of Diabetic Foot Infections (DFIs)
• Debridement: The First Step in Controlling DFIs
• Managing Infected DFUs
• Surgery Versus Antibiotics in Diabetic Foot Osteomyelitis
• IV Versus Oral Antibiotics for Osteomyelitis: Lessons from the OVIVA Trial
• Topical Treatments for DFIs
• Role of Modern Technology in the Prevention and Management of Biofilms and DFIs
• Conclusions
Prevention and Management of Diabetes-Related Eye Disease
THOMAS W. GARDNER, MD, MS; JENNIFER A. WYCKOFF, MD; ANJALI R. SHAH, MD; JILL E. BIXLER, MD; CHARLES C. WYKOFF, MD, PHD; BLAKE A. COOPER, MD; RAVI S.J. SINGH, MD
Published March 20, 2019
This publication has been supported by an unrestricted educational grant to the American Diabetes Association from Genentech.
Read the Monograph
PDF Version
- Introduction
- Optimizing Medical Management for Patients with Diabetes-Related Retinopathy
- Cataracts and Their Treatment in People with Diabetes
- Management of Diabetes-Related Retinopathy
- Emotional Support of People with
- Summary and Conclusion
Diagnosis and Management of Diabetic Foot Complications
Andrew J.M. Boulton, MD, DSc (Hon), FACP, FRCP; David G. Armstrong, DPM, MD, PhD; Robert S. Kirsner, MD, PhD; Christopher E. Attinger, MD; Lawrence A. Lavery, DPM, MPH; Benjamin A. Lipsky, MD, FACP, FIDSA, FRCP (London), FFPM, RCPS (Glasg); Joseph L. Mills, Sr., MD, FACS; John S. Steinberg, DPM, FACFAS
Published August 15, 2018
This publication was supported by unrestricted educational grants to the American Diabetes Association from Healogics, Inc., and Organogenesis, Inc.
Read the Monograph
PDF Version
- Introduction
- Pathways to Diabetic Foot Complications
- Screening for Foot Complications Risk
- When and Where to Refer Diabetic Foot Problems
- Off-Loading the Diabetic Foot Wound
- Wound Debridement: Surgical or Otherwise
- Recognizing and Treating Peripheral Artery Disease
- The Acute Hot, Swollen Foot: Charcot or Infection
Role of Continuous Glucose Monitoring in Diabetes Treatment
Irl B. Hirsch, MD; Tadej Battelino, MD, PhD; Anne L. Peters, MD, PhD; James J. Chamberlain, MD; Grazia Aleppo, MD, FACE, FACP; Richard M. Bergenstal, MD
Published June 5, 2018
This publication was supported by an educational grant to the American Diabetes Association from Abbott Diabetes Care.
Read the Monograph
PDF Version
- Introduction - History of Glucose Monitoring
- Continuous Glucose Monitoring Comes of Age
- The Evidence Base for Continuous Glucose Monitoring
- Continuous Glucose Monitoring Systems: Categories and Features
- Patient Selection for Continuous Glucose Monitoring
- Approaches for Successful Outcomes with Continuous Glucose Monitoring
- Continuous Glucose Monitoring Data as an Adjunct to A1C
- Understanding Continuous Glucose Monitoring Data
- The Future of Continuous Glucose Monitoring